Posted by john on June 28th, 2006 — in Ultram News
Postherpetic neuralgia is difficult to treat. Once PHN develops, a multidisciplinary approach that involves a pain specialist, psychiatrist, primary care physician, and other health-care providers may provide the best means to relieve the pain and distress associated with this condition. At this time, some experts recommend the following treatment steps:
First, topical preparations, usually the lidocaine […]
No Comments »
Posted by john on June 26th, 2006 — in Ultram News
Treatment for Postherpetic Neuralgia
Postherpetic neuralgia is difficult to treat. Once PHN develops, a multidisciplinary approach that involves a pain specialist, psychiatrist, primary care physician, and other health-care providers may provide the best means to relieve the pain and distress associated with this condition. At this time, some experts recommend the following treatment steps:
[…]
No Comments »
Posted by john on June 20th, 2006 — in Ultram News
ROCHESTER, Minn., June 16 — Acupuncture not only offered pain relief for fibromyalgia patients, but it significantly improved fatigue and anxiety symptoms, Mayo Clinic researchers reported.
This prospective, partially blinded, controlled, randomized trial included 50 fibromyalgia patients who had met American College of Rheumatology criteria for the disorder and had tried conservative treatments, including dietary […]
No Comments »
Posted by john on June 14th, 2006 — in Ultram News
Q. My doctor prescribed tramadol with APAP for headaches. He also wrote prescriptions for Lexapro and Effexor for depression and anxiety. He said that Effexor and Lexapro are both antidepressants, but they work on different parts of the brain. When I went to fill the new Lexapro and refill the tramadol prescription, the pharmacist would […]
No Comments »
Posted by john on June 11th, 2006 — in Ultram News
THURSDAY, May 25 (HealthDay News) — Used together, conventional and complementary/alternative treatments help patients ease their low back pain better than using mainstream treatment alone, U.S. research shows.
The small study included 13 patients who received “integrated” care and six patients who received usual care. The integrative care team at Brigham and Women’s Hospital in Boston […]
1 Comment »
Posted by john on June 8th, 2006 — in Ultram News
Dr. Krusz is a recognized expert in the fields of headache and Migraine treatment and pain treatment. To read more about Dr. Krusz, click HERE.
Please note: We cannot handle emergencies or diagnose via the Internet. Please do not ask us to diagnose; see your physician for diagnosis.
If you have a question for this section […]
No Comments »
Posted by john on June 5th, 2006 — in Ultram News
Biovail reported first-quarter results largely in-line with analyst and company expectations, with earnings of 43 cents per share and a 27% increase in total revenues to $220.5 million, from $175.3 million last year.
Revenues from strong sales of its lead product, Wellbutrin XL, helped Biovail (nyse: BVF - news - people ) meet or beat street […]
No Comments »
Posted by john on June 3rd, 2006 — in Ultram News
May 11 (Bloomberg) — Biovail Corp., Canada’s largest publicly traded drugmaker, said first-quarter profit climbed almost sixfold as labor costs declined and sales of the antidepressant Wellbutrin XL increased.
Net income rose to $64.5 million, or 40 cents a share, from $11.1 million, or 7 cents, a year earlier, Mississauga, Ontario- based Biovail said today […]
No Comments »
Posted by john on June 2nd, 2006 — in Ultram News
Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced financial results for the three-month period ending March 31, 2006. To the extent that this news release contains forward-looking statements, investors are cautioned that these are based on our current views, and actual outcomes are not certain. For more information, see the note on forward-looking information following the conference call […]
2 Comments »